1. Fujii, Atsushi, Masuda, Takaaki, Iwata, Michio, Nakamura, Masafumi, Mimori, Koshi. 2021. The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer. In Cancer science, 112, 1655-1668. doi:10.1111/cas.14858. https://pubmed.ncbi.nlm.nih.gov/33605496/
2. Seuter, Sabine, Ryynänen, Jussi, Carlberg, Carsten. 2013. The ASAP2 gene is a primary target of 1,25-dihydroxyvitamin D3 in human monocytes and macrophages. In The Journal of steroid biochemistry and molecular biology, 144 Pt A, 12-8. doi:10.1016/j.jsbmb.2013.08.014. https://pubmed.ncbi.nlm.nih.gov/23999061/
3. Ma, Xiao-Lu, Nie, Yan-Yan, Xie, Su-Hong, Guo, Lin, Lu, Ren-Quan. 2023. ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma. In Experimental hematology & oncology, 12, 38. doi:10.1186/s40164-023-00393-3. https://pubmed.ncbi.nlm.nih.gov/37061723/
4. Hu, Jing, Hu, Bin, Deng, Li, Fan, Qunhong, Lu, Caibao. . Arsenic sulfide inhibits the progression of gastric cancer through regulating the circRNA_ASAP2/Wnt/β-catenin pathway. In Anti-cancer drugs, 33, e711-e719. doi:10.1097/CAD.0000000000001246. https://pubmed.ncbi.nlm.nih.gov/34486534/
5. Tian, Renmao, Imanian, Behzad. 2022. ASAP 2: a pipeline and web server to analyze marker gene amplicon sequencing data automatically and consistently. In BMC bioinformatics, 23, 27. doi:10.1186/s12859-021-04555-0. https://pubmed.ncbi.nlm.nih.gov/34991446/
6. Zhao, Jie, Wang, Min, Deng, Wuquan, Chen, Bing, Zhang, Xiaoli. 2017. ADP-ribosylation factor-like GTPase 15 enhances insulin-induced AKT phosphorylation in the IR/IRS1/AKT pathway by interacting with ASAP2 and regulating PDPK1 activity. In Biochemical and biophysical research communications, 486, 865-871. doi:10.1016/j.bbrc.2017.03.079. https://pubmed.ncbi.nlm.nih.gov/28322786/
智鼠故事 
